Elisa Mauro

425 total citations
21 papers, 262 citations indexed

About

Elisa Mauro is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Elisa Mauro has authored 21 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Elisa Mauro's work include Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Elisa Mauro is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Elisa Mauro collaborates with scholars based in Italy and France. Elisa Mauro's co-authors include Barbara Sarina, Carmelo Carlo‐Stella, Stéfania Bramanti, Roberto Crocchiolo, Luca Castagna, Armando Santoro, Samia Harbi, Christian Chabannon, Bilal Mohty and Didier Blaise and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Elisa Mauro

21 papers receiving 261 citations

Peers

Elisa Mauro
M.-J. Zhang United States
A. Birgitta Versluijs Netherlands
Paula del Cerro United States
Jeff Schriber United States
N Basara Germany
Zina Chir France
Sanghee Hong United States
M. Ahsan Chaudhry Canada
Yajing Xu China
Myriam Labopin France
M.-J. Zhang United States
Elisa Mauro
Citations per year, relative to Elisa Mauro Elisa Mauro (= 1×) peers M.-J. Zhang

Countries citing papers authored by Elisa Mauro

Since Specialization
Citations

This map shows the geographic impact of Elisa Mauro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Mauro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Mauro more than expected).

Fields of papers citing papers by Elisa Mauro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Mauro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Mauro. The network helps show where Elisa Mauro may publish in the future.

Co-authorship network of co-authors of Elisa Mauro

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Mauro. A scholar is included among the top collaborators of Elisa Mauro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Mauro. Elisa Mauro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duminuco, Andrea, Salvatore Leotta, Elisa Mauro, et al.. (2025). Real-World Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia: Impact of NPM1 Mutations and Allogeneic Transplantation in a Retrospective Unicentric Cohort. Journal of Clinical Medicine. 14(14). 5110–5110. 1 indexed citations
2.
Duminuco, Andrea, Elisa Mauro, Vittorio Del Fabro, et al.. (2025). Chemotherapy extravasation: diagnosis, prevention and management. Journal of Chemotherapy. 38(2). 125–137. 1 indexed citations
3.
Vetro, Calogero, Uroš Markovic, Andrea Duminuco, et al.. (2023). A case of high‐risk AML in a patient with advanced systemic mastocytosis. SHILAP Revista de lepidopterología. 11(7). e7134–e7134. 4 indexed citations
4.
Gozzo, Lucia, Serena Brancati, Andrea Duminuco, et al.. (2023). Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data. Healthcare. 11(10). 1479–1479. 8 indexed citations
5.
Duminuco, Andrea, Uroš Markovic, Nunziatina Laura Parrinello, et al.. (2023). Potential clinical impact of T-cell lymphocyte kinetics monitoring in patients with B cell precursors acute lymphoblastic leukemia treated with blinatumomab: a single-center experience. Frontiers in Immunology. 14. 1195734–1195734. 2 indexed citations
6.
Duminuco, Andrea, et al.. (2022). Regression of leukemia cutis with gilteritinib in a case of FLT3-positive acute myeloid leukemia. SHILAP Revista de lepidopterología. 7. 100184–100184. 1 indexed citations
7.
Leotta, Salvatore, Andrea Duminuco, Antonino Mulè, et al.. (2022). Minimal Residual Disease Negativity after Blinatumomab Is Predictive of Survival in B-Cell Acute Lymphoblastic Leukemia: Data from a Real-Life Study. Blood. 140(Supplement 1). 11854–11855. 1 indexed citations
8.
Duminuco, Andrea, Calogero Vetro, Elisa Mauro, et al.. (2022). Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases. SHILAP Revista de lepidopterología. 14(2). 67–72. 5 indexed citations
9.
Vetro, Calogero, Andrea Duminuco, Lucia Gozzo, et al.. (2022). Pegylated Asparaginase‐Induced Liver Injury: A Case‐Based Review and Data From Pharmacovigilance. The Journal of Clinical Pharmacology. 62(9). 1142–1150. 5 indexed citations
10.
Duminuco, Andrea, Elisa Mauro, Paolo Fiumara, et al.. (2022). Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field. Cancers. 14(9). 2186–2186. 13 indexed citations
11.
Duminuco, Andrea, et al.. (2021). Therapeutic Innovation for Multi-Resistant Candidemics: Synergy of Isavuconazole and Caspofungin Association. Hematology Reports. 13(4). 9329–9329. 1 indexed citations
12.
Gozzo, Lucia, Calogero Vetro, Serena Brancati, et al.. (2021). Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database. Frontiers in Pharmacology. 12. 748766–748766. 14 indexed citations
13.
Olíva, Esther Natalie, Anna Candoni, Prassede Salutari, et al.. (2019). Azacitidine for Post-Remission Therapy in Elderly Patients with Acute Myeloid Leukemia : Final Results of the Qoless AZA-Amle Randomized Trial. Blood. 134(Supplement_1). 117–117. 7 indexed citations
14.
15.
Bramanti, Stéfania, Angela Nocco, Elisa Mauro, et al.. (2016). Desensitization with plasma exchange in a patient with human leukocyte antigen donor‐specific antibodies before T‐cell–replete haploidentical transplantation. Transfusion. 56(5). 1096–1100. 11 indexed citations
16.
Chiaretti, Sabina, Monica Messina, Francesca Paoloni, et al.. (2015). CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. Leukemia Research. 41. 36–42. 35 indexed citations
17.
Castagna, Luca, Roberto Crocchiolo, Sabine Fürst, et al.. (2014). Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide. Biology of Blood and Marrow Transplantation. 20(5). 724–729. 116 indexed citations
18.
19.
Orciuolo, Enrico, Gabriele Buda, Elisa Mauro, et al.. (2010). Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization. Leukemia Research. 35(7). 899–903. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.-J. Zhang Breakdown of academic impact, for papers by A. Birgitta Versluijs Breakdown of academic impact, for papers by Paula del Cerro Breakdown of academic impact, for papers by Jeff Schriber Breakdown of academic impact, for papers by N Basara Breakdown of academic impact, for papers by Zina Chir Breakdown of academic impact, for papers by Sanghee Hong Breakdown of academic impact, for papers by M. Ahsan Chaudhry Breakdown of academic impact, for papers by Yajing Xu Breakdown of academic impact, for papers by Myriam Labopin
Rankless by CCL
2026